N1,N1'-(Butane-1,4-diyl)bis(N3-ethylpropane-1,3-diamine) tetrahydrochloride

Catalog No. :
ACYSLR062
CAS No. :
113812-15-0
Molecular Formula :
C14H38Cl4N4
Molecular Weight :
404.30

IUPAC Name:N1,N1'-(butane-1,4-diyl)bis(N3-ethylpropane-1,3-diamine) tetrahydrochloride

N1,N1'-(Butane-1,4-diyl)bis(N3-ethylpropane-1,3-diamine) tetrahydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN1,N1'-(Butane-1,4-diyl)bis(N3-ethylpropane-1,3-diamine) tetrahydrochloride
IUPAC NameN1,N1'-(butane-1,4-diyl)bis(N3-ethylpropane-1,3-diamine) tetrahydrochloride
Molecular FormulaC14H38Cl4N4
Molecular Weight404.30
SMILESCCNCCCNCCCCNCCCNCC.[H]Cl.[H]Cl.[H]Cl.[H]Cl
InChI KeySCYOBNRPMHJGLB-UHFFFAOYSA-N
SynonymN1, N12-DIETHYLSPERMINE 4HCL;N1,N12-DIETHYLSPERMINE TETRAHYDROCHLORIDE;N1,N12-Diethylapermine Tetrahydrochloride;N,N'-bis[3-(ethylamino)propyl]butane-1,4-diamine tetrahydrochloride;N(1),N(12)-Diethylspermine-d10 4HCl;N1,N12-Diethylspermi
CAS No.113812-15-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYSLR062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHPQJ189 route compound structure diagram
    ACHPQJ18910563-23-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYSLR062 route product structure diagram
    ACYSLR062113812-15-0
Inquiry

2. ACYSLR062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYSLR062 route product structure diagram
    ACYSLR062113812-15-0
Inquiry

Comments (0)